AMERICAN REGENT, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1967-01-01
- Employees
- 501
- Market Cap
- -
Safety and Pharmacokinetics Study of Intranasal Ketorolac in Elderly and Nonelderly Adult Healthy Subjects
- First Posted Date
- 2011-06-03
- Last Posted Date
- 2013-02-06
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT01365624
- Locations
- 🇺🇸
Seaview Research, Miami, Florida, United States
Study of the Safety, Tolerability and Analgesic Efficacy of Multiple Doses of Ketorolac Tromethamine (IN) for Postoperative Pain
- First Posted Date
- 2011-05-10
- Last Posted Date
- 2012-10-18
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 127
- Registration Number
- NCT01351090
- Locations
- 🇳🇿
Waikato Clinical Research, Hamilton, New Zealand
Hypophosphatemia With Ferric Carboxymaltose Vs. Iron Dextran in Iron Deficiency Secondary to Heavy Uterine Bleeding
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-03-02
- Last Posted Date
- 2018-02-19
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 69
- Registration Number
- NCT01307007
Intravenous Ferric Carboxymaltose vs IV Iron Sucrose or IV Iron Dextran in Treating Iron Deficiency Anemia in Women
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2018-02-08
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01290315
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
Bioequivalence Trial of Luitpold Azacitidine Versus Vidaza® in Patients With Myelodysplastic Syndrome, Myelofibrosis, Chronic Myeloid Leukemia or Chronic Lymphocytic Leukemia
Phase 1
Completed
- Conditions
- Interventions
- First Posted Date
- 2011-02-07
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT01290302
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
Safety Assessment of Iron Sucrose (Venofer) in Patients With Chronic Kidney Disease Who Cannot Tolerate Ferumoxytol (Feraheme) or Iron Dextran (INFed or Dexferrum)
Phase 4
Withdrawn
- Conditions
- First Posted Date
- 2010-06-28
- Last Posted Date
- 2018-01-24
- Lead Sponsor
- American Regent, Inc.
- Registration Number
- NCT01151592
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
Efficacy and Safety of Intravenous Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia (IDA)
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 997
- Registration Number
- NCT00982007
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
Evaluation of Efficacy and Safety of Ferric Carboxymaltose (FCM) in Patients With Iron Deficiency Anemia and Impaired Renal Function
Phase 3
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-09-22
- Last Posted Date
- 2018-02-20
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 2561
- Registration Number
- NCT00981045
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Inc., Norristown, Pennsylvania, United States
Iron Sucrose In The Treatment of Restless Legs Syndrome: Safety of Three Dose Regimens as Evaluated by Clinical Assessments
Phase 2
Completed
- Conditions
- Interventions
- First Posted Date
- 2009-05-08
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 21
- Registration Number
- NCT00895232
Safety and Tolerability of Intravenous VIT-45 in Patients With Iron Deficiency Anemia
Phase 3
Completed
- Conditions
- First Posted Date
- 2008-08-22
- Last Posted Date
- 2008-08-22
- Lead Sponsor
- American Regent, Inc.
- Registration Number
- NCT00740246
- Locations
- 🇺🇸
Luitpold Pharmaceuticals, Norristown, Pennsylvania, United States
© Copyright 2024. All Rights Reserved by MedPath